Skip to main content

Table 2 Prevalence of MDM2SNP309 subtypes

From: Effects of the single nucleotide polymorphism at MDM2 309 on breast cancer patients with/without BRCA1/2 mutations

 

BRCA1

BRCA2

BRCA1+2

Total

a: Prevalence of the MDM2 SNP309 subtypes in BRCA mutation carriers

Homozygotes G-G

29(26.1)%

16(23%)

 

45(25%)

Hetrozygotes

55(49.5%)

39(57.3%)

 

94(52.2%)

Homozygotes T-T

27(24.3%)

13(19.1%)

1(100%)

41(22.7%)

Total

111

68

1

180

b: Prevalence of the MDM2 SNP309 subtypes in the overall population

 

BRCA Carriers

Non Carriers

 

Frequency

Percent

Frequency

Percent

Homozygotes G-G

45

25.00%

68

25.00%

Hetrozygotes

94

52.20%

139

51.10%

Homozygotes T-T

41

22.80%

65

23.90%

Total

180

 

272